CROI 2017 Program and Information

Program and Agenda

F. NEUROPATHOGENESIS AND CNS HIV COMPLICATIONS P-F1 THE CNS AND SYSTEMATIC IMMUNE ACTIVATION (Thursday) P-F2 CEREBROVASCULAR EVENTS AND HIV (Wednesday) P-F3 NEUROCOGNITIVE FUNCTIONING, VIRAL SUPPRESSION, AND ASSOCIATED RISKS (Thursday) P-F4 CNS RESERVOIRS/ESCAPE (Wednesday) P-F5 VIROLOGY/BASIC NEUROSCIENCE (Tuesday) P-F6 INTERVENTION-FOCUSED (Tuesday) P-F7 HOST AND VIRAL BIOMARKERS (Tuesday) P-F8 NEUROIMAGING AND ASSOCIATED BIOMARKERS (Wednesday) G. CLINICAL PHARMACOLOGY P-G1 INTRACELLULAR AND TISSUE PHARMACOLOGY (Tuesday) P-G2 DRUG - DRUG INTERACTIONS (Wednesday) P-G3 PHARMACOKINETICS AND PHARMACOGENETICS: NEW AND EXISTING DRUGS AND FORMULATIONS (Tuesday) P-G4 EXPOSURE-RESPONSE RELATIONSHIPS OF ANTIRETROVIRAL DRUGS (Wednesday) P-G5 ANTIRETROVIRAL PHARMACOKINETICS: SPECIAL PROBLEMS AND POPULATIONS (Thursday) H. ANTIRETROVIRAL THERAPY: PRE-CLINICAL AND RANDOMIZED TRIALS P-H1 I WANT A NEW DRUG (Wednesday) P-H2 ANTIRETROVIRAL CLINICAL TRIALS (Tuesday) I. ANTIRETROVIRAL THERAPY: EFFICACY AND EFFECTIVENESS STUDIES P-I1 ART: SAFETY AND PRESCRIBING OVER THE LONG TERM (Tuesday) P-I2 MAINTENANCE: SECOND- AND THIRD-LINE THERAPY (Tuesday) P-I3 ART: VIRAL RESPONSE OVER THE LONG TERM (Wednesday) P-I4 ART: PREDICTORS OF OUTCOMES (Wednesday) P-I5 IMMEDIATE VS DELAYED ART (Thursday) J. HIV DRUG RESISTANCE P-J1 PREVALENCE AND INCIDENCE OF HIV DRUG RESISTANCE (Thursday) P-J2 IMPACT OF RESISTANCE ON RESPONSE TO ART (Thursday) P-J3 INTEGRASE STRAND TRANSFER INHIBITOR RESISTANCE (Tuesday) P-J4 REVERSE TRANSCRIPTASE INHIBITOR RESISTANCE (Tuesday) P-J5 RESISTANCE TO PROTEASE AND MATURATION INHIBITORS (Tuesday) K. HIV DIAGNOSTICS P-L1 HCV TRANSMISSION: THE CASCADE IS NOT RUNNING DRY (Tuesday) P-L2 PROGRESSION OF LIVER DISEASE IN THE HCV-INFECTED POPULATION (Tuesday) P-L3 HCV: PROGRESSION TO CIRRHOSIS AND HEPATOCELLULAR CARCINOMA (Tuesday) P-L4 HCV: THE RAINBOW AT THE END OF THE CASCADE (Wednesday) P-K1 HIV DETECTION AND RECENCY METHODS (Tuesday) L. HEPATITIS VIRUSES AND LIVER COMPLICATIONS

Poster Sessions

P-L5 HCV: RESISTANCE AND RETREATMENT (Wednesday) P-L6 DAAs: TREATMENT AND ITS COMPLEXITIES (Wednesday) P-L7 HEPATITIS IS NOT ALL C (Thursday) P-L8 PATHOGENESIS OF HCV INFECTION (Thursday)

CROI 2017 213